# LEVOMILNACIPRAN
> **ANDA210805** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2020-06-01
## Drug
- **FDA Application Number:** ANDA210805
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOMILNACIPRAN
- **Generic name:** Levomilnacipran
- **Active ingredients:** LEVOMILNACIPRAN
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABORATORIES PRIVATE LTD
- **First approval:** 2020-06-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210805)
---
*MORVS · CC0 1.0*